Blood test for lung cancer circulating tumour DNA (ctDNA)  study

This is a study aimed to improve lung cancer survival rates by identifying lung cancer DNA in blood.


Contact information

Ernest Tang, ctDNA Study Coordinator
Phone: 604-202-6266

Purpose of this study

Untreated lung cancer is a lethal disease and is the most common cancer diagnosed in both men and women in Canada.
This research study uses liquid biopsy technology with patient blood samples to assess for Lung Cancer circulating tumour DNA (ctDNA) and the impact on survival.

Who Can Participate?

Men and women aged 18 or older, that will have lung cancer treated with surgery.

Study Leadership

The Lung ctDNA study  is led by principal investigator Dr. A. McGuire (VGH Thoracic Surgery).



Gordon and Leslie Diamond Health Care Centre, Vancouver General Hospital

2775 Laurel Street, 7th floor

Vancouver, BC, V5Z 1M9

Thoracic Office Hours:

9:00am - 4:00pm Monday - Friday

Closed 12:00-1:00pm for lunch, weekends, and statutory holidays




©2020 by Vancouver Thoracic Surgery, Vancouver Coastal Health Patient Education Materials